Curis Lifesciences Limited IPO

Established in 2010, Curis Lifesciences Limited is a pharmaceutical company that focuses on the development, manufacturing, and distribution of a diverse range of products. The company manufactures its pharmaceutical products both for global and domestic markets on a loan license or contract basis, as well as for its own brand marketing. Its product categories include general pharmaceutical tablets and capsules, oral liquids, external preparations, and sterile ophthalmic ointments.

Don't have a Navia account? Sign up

Curis Lifesciences serves over 100 corporate clients through its loan license and contract manufacturing services, and markets its own brands to two clients in Yemen and Kenya. The company operates a state-of-the-art manufacturing facility in Sanand, Gujarat, where it adheres to stringent quality control measures to ensure high standards of product safety and efficacy. As of July 31, 2025, the company employed 95 permanent employees.

How do I apply for the Curis Lifesciences IPO?

You can apply for the Curis Lifesciences IPO using any supported UPI app by following two steps:

• Enter your bid on rocket
• Accept UPI mandate on your phone

On acceptance of the mandate, the bid amount will get blocked in your bank account.